Medications · FAQ
Are Verra's compounded pilocarpine troches FDA-approved?
Short answer
No. Verra's compounded pilocarpine troches are not FDA-approved. They are prepared by a licensed pharmacy for one patient. FDA-approved pilocarpine tablets have specific dry mouth uses, but that approval does not extend to compounded troches. A physician licensed in your state decides whether a troche is appropriate.
Verra offers compounded pilocarpine troches, which are not FDA-approved. Compounded medications are prepared by a licensed pharmacy for one patient. The FDA does not review each compounded product for safety, effectiveness, or quality before it is sold.
There are FDA-approved pilocarpine tablets for dry mouth caused by Sjogren's syndrome or radiation to the head and neck. That approval does not apply to a compounded troche. A troche has a different dosage form, and its directions may differ from tablet directions. You should not replace one form with another or compare doses on your own.
A physician licensed in your state decides whether a compounded troche is appropriate after reviewing your health history and treatment needs. Ask why this dosage form is being considered and what other options may be available.
Before starting, read the pharmacy label and check the strength, ingredients, storage directions, and beyond-use date. Ask the pharmacist about anything unclear, including flavorings or other ingredients if you have allergies. Do not use someone else's prescription.
Sources
Written by the Verra clinical team · Medical review pending
General information, not medical advice. If you're in crisis, call or text 988.